Boston Scientific


 

ATLAS and the Weight of Experience

0 views
August 24, 2022

Dr. Jeff Healey and Professor Pier  Lambiase discuss the results of the ATLAS  trial, evaluating and comparing the lead related complications between TV-ICD and  EMBLEM S-ICD patients, and key  secondary endpoints including inappropriate shocks.

Comments 0
Login to view comments. Click here to Login